This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07680/identifier/pdb/
n7http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB07680/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07680/identifier/pubchem-substance/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07680/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07680/identifier/chemspider/

Statements

Subject Item
n2:DB07680
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB07680 n7:DB07680
dcterms:title
[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID
adms:identifier
n9:99444151 n11:DRX n12:16122567 n13:17279485 n14:DB07680
n5:IUPAC-Name
n6:271B5C1A-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5C20-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5C1F-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5C1C-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5C1D-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5C1E-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5C18-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5C16-363D-11E5-9242-09173F13E4C5 n6:271B5C19-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5C17-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5C26-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5C27-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5C21-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5C22-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5C24-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5C23-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5C25-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5C2C-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5C2E-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5C2F-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5C2B-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5C2A-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5C2D-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5C1B-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5C28-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5C29-363D-11E5-9242-09173F13E4C5